Patents by Inventor Fausto Pivetti

Fausto Pivetti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10350164
    Abstract: A process for preparing a dry powder formulation for inhalation comprising a combination of an anti-cholinergic, a long-acting beta2-adrenoceptor agonist, and, optionally, an inhaled corticosteroid, is provided.
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: July 16, 2019
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Alessandro Cavecchi, Cristiana Merusi, Fausto Pivetti, Francesca Schiaretti
  • Patent number: 10323003
    Abstract: The present invention relates to a process for the preparation of compounds endowed with phosphodiesterase (PDE4) inhibitory activity having formula (I). The invention also relates to the process for the isolation by crystallization of the compound (I) and to its use for the preparation of pharmaceutical compositions for inhalation in combination with suitable carriers or vehicles. The present invention also relates to solvates and crystal forms of a compound of formula (I). The synthesized product is suitable for use in pharmaceutical applications for instance in the treatment of respiratory diseases.
    Type: Grant
    Filed: November 3, 2017
    Date of Patent: June 18, 2019
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Alessandro Falchi, Emilio Lutero, Emanuele Ferrari, Fausto Pivetti, Rocco Bussolati, Edoardo Mariani, Orsola Vecchi, Erhard Bappert, Caterina Ventrici
  • Publication number: 20180325815
    Abstract: A process for preparing a dry powder formulation for inhalation comprising a combination of an anti-cholinergic, a long-acting beta2-adrenoceptor agonist, and, optionally, an inhaled corticosteroid, is provided.
    Type: Application
    Filed: May 9, 2018
    Publication date: November 15, 2018
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Alessandro CAVECCHI, Cristiana MERUSI, Fausto PIVETTI, Francesca SCHIARETTI
  • Publication number: 20180325816
    Abstract: A process for preparing a dry powder formulation for inhalation comprising a combination of an anti-cholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid is provided.
    Type: Application
    Filed: May 9, 2018
    Publication date: November 15, 2018
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Alessandro CAVECCHI, Cristiana MERUSI, Fausto PIVETTI, Francesca SCHIARETTI
  • Publication number: 20180118686
    Abstract: The present invention relates to a process for the preparation of compounds endowed with phosphodiesterase (PDE4) inhibitory activity having formula (I). The invention also relates to the process for the isolation by crystallization of the compound (I) and to its use for the preparation of pharmaceutical compositions for inhalation in combination with suitable carriers or vehicles. The present invention also relates to solvates and crystal forms of a compound of formula (I). The synthesized product is suitable for use in pharmaceutical applications for instance in the treatment of respiratory diseases.
    Type: Application
    Filed: November 3, 2017
    Publication date: May 3, 2018
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Alessandro FALCHI, Emilio LUTERO, Emanuele FERRARI, Fausto PIVETTI, Rocco BUSSOLATI, Edoardo MARIANI, Orsola VECCHI, Erhard BAPPERT, Caterina VENTRICI
  • Patent number: 9890122
    Abstract: The present invention relates to a process for the preparation of compounds endowed with phosphodiesterase (PDE4) inhibitory activity having formula (I). The invention also relates to the process for the isolation by crystallization of the compound (I) and to its use for the preparation of pharmaceutical compositions for inhalation in combination with suitable carriers or vehicles. The present invention also relates to solvates and crystal forms of a compound of formula (I). The synthesized product is suitable for use in pharmaceutical applications for instance in the treatment of respiratory diseases.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: February 13, 2018
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Alessandro Falchi, Emilio Lutero, Emanuele Ferrari, Fausto Pivetti, Rocco Bussolati, Edoardo Mariani, Orsola Vecchi, Erhard Bappert, Caterina Ventrici
  • Publication number: 20160326117
    Abstract: The present invention relates to a process for the preparation of compounds endowed with phosphodiesterase (PDE4) inhibitory activity having formula (I). The invention also relates to the process for the isolation by crystallization of the compound (I) and to its use for the preparation of pharmaceutical compositions for inhalation in combination with suitable carriers or vehicles. The present invention also relates to solvates and crystal forms of a compound of formula (I). The synthesized product is suitable for use in pharmaceutical applications for instance in the treatment of respiratory diseases.
    Type: Application
    Filed: July 22, 2016
    Publication date: November 10, 2016
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Alessandro FALCHI, Emilio Lutero, Emanuele Ferrari, Fausto Pivetti, Rocco Bussolati, Edoardo Mariani, Orsola Vecchi, Erhard Bappert, Caterina Ventrici
  • Patent number: 9434691
    Abstract: The present invention relates to a process for the preparation of compounds endowed with phosphodiesterase (PDE4) inhibitory activity having formula (I). The invention also relates to the process for the isolation by crystallization of the compound (I) and to its use for the preparation of pharmaceutical compositions for inhalation in combination with suitable carriers or vehicles. The present invention also relates to solvates and crystal forms of a compound of formula (I). The synthesized product is suitable for use in pharmaceutical applications for instance in the treatment of respiratory diseases.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: September 6, 2016
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Alessandro Falchi, Emilio Lutero, Emanuele Ferrari, Fausto Pivetti, Rocco Bussolati, Edoardo Mariani, Orsola Vecchi, Erhard Bappert, Caterina Ventrici
  • Publication number: 20160193165
    Abstract: Novel polymorphic forms and salts of 1-(3?,4?-dichloro-2-fluorobiphenyl-4-yl)cyclopropanecarboxylic acid are useful for the prevention or treatment of Alzheimer's Disease.
    Type: Application
    Filed: March 17, 2016
    Publication date: July 7, 2016
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Fausto PIVETTI, Maurizio DELCANALE, Stefano Luca GIAFFREDA, Marco CURZI
  • Patent number: 9174937
    Abstract: A new crystal form of threo glycopyrronium chloride is useful in pharmaceutical applications.
    Type: Grant
    Filed: June 14, 2011
    Date of Patent: November 3, 2015
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Fausto Pivetti, Monica Bocchi, Enrico Vigano, Ernesto Landonio
  • Patent number: 9056818
    Abstract: Compounds according to formula (IA): may be efficiently prepared by the disclosed process.
    Type: Grant
    Filed: July 29, 2010
    Date of Patent: June 16, 2015
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Fausto Pivetti, Maria Gioia Fornaretto, Marco Re
  • Publication number: 20150111931
    Abstract: The present invention relates to a process for the preparation of compounds endowed with phosphodiesterase (PDE4) inhibitory activity having formula (I). The invention also relates to the process for the isolation by crystallization of the compound (I) and to its use for the preparation of pharmaceutical compositions for inhalation in combination with suitable carriers or vehicles. The present invention also relates to solvates and crystal forms of a compound of formula (I). The synthesized product is suitable for use in pharmaceutical applications for instance in the treatment of respiratory diseases.
    Type: Application
    Filed: October 17, 2014
    Publication date: April 23, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Alessandro FALCHI, Emilio LUTERO, Emanuele FERRARI, Fausto PIVETTI, Rocco BUSSOLATI, Edoardo MARIANI, Orsola VECCHI, Erhard BAPPERT, Caterina VENTRICI
  • Publication number: 20140364479
    Abstract: The invention concerns a method for preparing glycopyrronium chloride, and its use in pharmaceutical applications.
    Type: Application
    Filed: August 27, 2014
    Publication date: December 11, 2014
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Fausto PIVETTI, Monica Bocchi, Emanuele Ferrari
  • Patent number: 8877164
    Abstract: Aerosol solution formulation for use in an aerosol inhaler which includes at least one active ingredient selected from 20-ketosteroids and quinolinone derivatives, a propellant containing a hydrofluoroalkane, a cosolvent, and a specific amount of a sequestering agent that stabilizes the formulation. By way of example, the stabilizing agent may be phosphoric acid or sulphuric acid.
    Type: Grant
    Filed: February 24, 2006
    Date of Patent: November 4, 2014
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: David Andrew Lewis, Brian John Meakin, Maurizio Delcanale, Fausto Pivetti
  • Publication number: 20140135399
    Abstract: Novel polymorphic forms and salts of 1-(3?,4?-dichloro-2-fluorobiphenyl-4-yl)cyclopropanecarboxylic acid are useful for the prevention or treatment of Alzheimer's Disease.
    Type: Application
    Filed: January 23, 2014
    Publication date: May 15, 2014
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Fausto Pivetti, Maurizio Delcanale, Stefano Luca Giaffreda, Marco Curzi
  • Patent number: 8673978
    Abstract: Novel polymorphic forms and salts of 1-(3?,4?-dichloro-2-fluorobiphenyl-4-yl)cyclopropanecarboxylic acid are useful for the prevention or treatment of Alzheimer's Disease.
    Type: Grant
    Filed: April 1, 2011
    Date of Patent: March 18, 2014
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Fausto Pivetti, Maurizio Delcanale, Stefano Luca Giaffreda, Marco Curzi
  • Patent number: 8399406
    Abstract: Reconstituted pulmonary surfactants comprising a lipid carrier, a combination of polypeptide analog of the native surfactant protein SP-C with a particular polypeptide analog of the native surfactant protein SP-B may be used for the treatment or prophylaxis of RDS and other respiratory disorders.
    Type: Grant
    Filed: May 27, 2010
    Date of Patent: March 19, 2013
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Fausto Pivetti, Monica Bocchi, Annamaria Soliani Raschini
  • Patent number: 8163922
    Abstract: 8-hydroxy-5-[(1R)-1-hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride of formula (I) may be conveniently prepared in a diastereomeric pure form from optically pure precursors that are readily available by simple resolution and asymmetric reduction.
    Type: Grant
    Filed: July 30, 2009
    Date of Patent: April 24, 2012
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Fausto Pivetti, Monica Bocchi, Maurizio Delcanale
  • Patent number: 8128909
    Abstract: Disclosed is a process for the preparation of sterile aqueous suspensions based on active ingredients in the form of micronised crystalline particles designed for administration by inhalation. In particular, a process for the preparation of sterile aqueous suspensions based on pharmaceutical active ingredients in the form of crystalline hydrates is disclosed.
    Type: Grant
    Filed: December 17, 2003
    Date of Patent: March 6, 2012
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Andrea Capocchi, Fausto Pivetti
  • Publication number: 20110306650
    Abstract: The invention concerns a method for preparing glycopyrronium chloride, and its use in pharmaceutical applications.
    Type: Application
    Filed: June 14, 2011
    Publication date: December 15, 2011
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Fausto PIVETTI, Monica Bocchi, Emanuele Ferrari